Table 5.

Univariate analysis for risk factors associated with CAV-free survival 10 years after Htx

Risk factor	HR	95 % CI	p-value
Recipient male	1.18	0.79–1.76	0.417
Recipient age	1.01	1.00–1.03	0.034
Recipient body mass index	1.03	0.99–1.08	0.137
Donor male	1.13	0.79–1.63	0.491
Donor age	1.04	1.03–1.06	<0.001
CAD	1.65	1.18–2.30	0.003
No CMV	-	-	Ref.
CMV disease	2.03	1.39–2.95	<0.001
Asymptomatic CMV infection	1.63	1.07–2.46	0.022
Donor-related CAD	1.49	0.86–2.59	0.153
Cold ischemic time	1.00	0.99–1.00	0.518
AMR at first year	1.18	0.71–1.96	0.531
TRS	1.51	0.84–2.72	0.165
TRS ≥ 2R	2.07	0.87–4.93	0.099
Hypertension	1.39	0.89–2.18	0.146
Diabetes mellitus	1.05	0.85–1.30	0.646
Ex-smoker	1.23	0.87–1.76	0.245
CMV serology
D−/R−	-	-	-
D−/R+	1.22	0.57–2.62	0.602
D+/R−	1.80	0.82–3.91	0.141
D+/R+	1.50	0.72–3.12	0.278

Ref reference category when calculating HR